Watson Pharmaceuticals (NYSE: WPI) reported Thursday that it set its 2010 profit and revenue guidance that meet Wall Street expectations, according to Associated Press.
The outlook was given as the company held its annual investor's conference in New York on Thursday. It comes a week after the company said its 2009 profit and revenue could top its previous predictions.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
The company is scheduled to report 2009 results Feb. 23.
In 2010, the company expects profit between $3.05 and $3.30 per share on revenue of about $3.5 billion. Analysts polled by Thomson Reuters expect profit of about $3.13 per share on revenue of about $3.46 billion.
On Jan. 13, the company said sales of branded and generic drugs could push 2009 profit above guidance. The company had set 2009 profit guidance between $2.50 and $2.58 per share, on revenue of $2.7 billion. Analysts at the time had forecast 2009 profit of $2.57 per share on $2.74 billion in revenue.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.